Literature DB >> 4208532

Activity of carbenicillin and ticarcillin against Pseudomonas aeruginosa compared by paired in vitro tests.

K Mai, B Bülow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4208532     DOI: 10.1007/bf01642217

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

1.  [Carbenicillin. Experimental studies on the antibacterial activity and clinical pharmacology].

Authors:  P Naumann; J Kempf
Journal:  Arzneimittelforschung       Date:  1969-08

2.  -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.

Authors:  R Sutherland; J Burnett; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

3.  Comparison between carbenicillin and a -carboxyl-3-thienylmethyl penicillin (BRL 2288), a new semisynthetic penicillin active against Pseudomonas aeruginosa.

Authors:  J Klastersky; D Daneau
Journal:  Curr Ther Res Clin Exp       Date:  1972-08

4.  Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.

Authors:  H C Neu; E B Winshell
Journal:  Appl Microbiol       Date:  1971-01

5.  In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.

Authors:  G P Bodey; B Deerhake
Journal:  Appl Microbiol       Date:  1971-01
  5 in total
  3 in total

1.  Clinical and pharmacological studies of ticarcillin in gram-negative infections.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].

Authors:  A Bauernfeind; C Petermüller; M Dietzel
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Ticarcillin in the treatment of experimental pseudomonas keratitis.

Authors:  A Ahmad; G Smolin; M Okumoto; S Ohno
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.